HNSBF - Hansa Biopharma GAAP EPS of -SEK 3.19 revenue of SEK 31M February, 02 2023 04:51 AM Hansa Biopharma AB Hansa Biopharma press release ( OTCPK:HNSBF ): Q4 GAAP EPS of -SEK 3.19. Revenue of SEK 31M (+101.3% Y/Y). Cash runway extended into 2025. For further details see: Hansa Biopharma GAAP EPS of -SEK 3.19, revenue of SEK 31M